Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2

Affiliations

• ¹ Pharmacognosy Research Laboratories and Herbal Analysis Services, University of Greenwich, Central Avenue, Chatham-Maritime, Kent ME4 4TB, United Kingdom.
• ² Baqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Tehran, Iran.
• ³ Department of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada.
• ⁴ Research Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Functional Sciences, Immunology and Allergology, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, Romania.
• ⁵ Research Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania; The Research Center for Advanced Medicine- Medfuture- "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, Romania; The Functional Genomics and Experimental Pathology - The Oncology Institute "Prof. Dr. Ion Chiricuta", Romania.
• ⁶ Baqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Tehran, Iran. Electronic address: Nabavi208@gmail.com.